Mosquito Repellent Market Size Expected to Reach US $5.00 Billion by 2022: Zion Market Research
/
Date28 Feb 2018
New York, NY, Feb. 28, 2018 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Mosquito Repellent Market by Source (Synthetic Chemical... Read More →
Siyata Mobile Expands Global Distribution
/
Date28 Feb 2018
MONTREAL, Feb. 28, 2018 (GLOBE NEWSWIRE) — Siyata Mobile Inc. (the “Company” or “Siyata“) (TSX-V:SIM) (OTCQX:SYATF) is pleased to announce it has entered an agreement... Read More →
Laurentian Bank Declares a Dividend on Its Common Shares
/
Date28 Feb 2018
MONTREAL, Feb. 28, 2018 (GLOBE NEWSWIRE) — At its meeting held on February 27, 2018, the Board of Directors of the Laurentian Bank of Canada... Read More →
Evogene Reports Fourth Quarter and Full Year 2017 Financial Results
/
Date28 Feb 2018
REHOVOT, Israel, Feb. 28, 2018 (GLOBE NEWSWIRE) — Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company developing novel products for life science markets through the... Read More →
TDC : Publication of offer document
/
Date28 Feb 2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE... Read More →
Parker to Webcast New York Investor Meeting March 7 at 1:00 p.m. Eastern Time
/
Date28 Feb 2018
CLEVELAND, Feb. 27, 2018 (GLOBE NEWSWIRE) — Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it will... Read More →
Raisio Oyj: Tilinpäätös 2017, selvitys hallinto- ja ohjausjärjestelmästä 2017 sekä palkka- ja palkkioselvitys 2017 julkaistu
/
Date28 Feb 2018
Raisio Oyj Pörssitiedote 28.2.2018 Tilinpäätös 2017, selvitys hallinto- ja ohjausjärjestelmästä 2017 sekä palkka- ja palkkioselvitys 2017 julkaistu Raisio Oyj:n tilinpäätös ja toimintakertomus 31.12.2017 päättyneeltä tilikaudelta... Read More →
Achillion Raises Awareness for C3 Glomerulopathy With Launch of WeC3G™ Initiative as Part of Rare Disease Day 2018
/
Date28 Feb 2018
February 28, 2018 is the 11th Annual Rare Disease Day Achillion sponsors initiative to help shine the light on C3G to raise awareness and understanding... Read More →
Atara Biotherapeutics Announces Proposed Offering of Common Stock
/
Date28 Feb 2018
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) — Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients... Read More →